UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update

Annals of internal medicine, 2018-03, Vol.168 (6), p.422

2018

Volltextzugriff (PDF)

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

American journal of nephrology, 2017-01, Vol.45 (3), p.187-199

2017

Volltextzugriff (PDF)

Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10), p.2435-2438

2021

Volltextzugriff (PDF)

A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD

Journal of the American Society of Nephrology, 2019-08, Vol.30 (8), p.1495-1504

2019

Volltextzugriff (PDF)

SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey

Journal of the American Society of Nephrology, 2021-07, Vol.32 (7), p.1575-1581

2021

Volltextzugriff (PDF)

Effects of Phosphate Binders in Moderate CKD

Journal of the American Society of Nephrology, 2012-08, Vol.23 (8), p.1407-1415

2012

Volltextzugriff (PDF)

Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial

Clinical journal of the American Society of Nephrology, 2017-02, Vol.12 (2), p.315-322

2017

Volltextzugriff (PDF)

Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis

Journal of the American Society of Nephrology, 2017-06, Vol.28 (6), p.1933-1942

2017

Volltextzugriff (PDF)

Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial

Journal of the American Society of Nephrology, 2019-06, Vol.30 (6), p.1096-1108

2019

Volltextzugriff (PDF)

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

American journal of nephrology, 2018-01, Vol.47 (1), p.40-47

2018

Volltextzugriff (PDF)

A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5

American journal of kidney diseases, 2015-05, Vol.65 (5), p.728-736

2015

Volltextzugriff (PDF)

Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD

Clinical journal of the American Society of Nephrology, 2014-03, Vol.9 (3), p.543-552

2014

Volltextzugriff (PDF)

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD

Journal of the American Society of Nephrology, 2015-10, Vol.26 (10), p.2328-2339

2015

Volltextzugriff (PDF)

Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosis

Atherosclerosis, 2016-11, Vol.254, p.93-101

2016

Volltextzugriff (PDF)

CKD–Mineral and Bone Disorder and Risk of Death and Cardiovascular Hospitalization in Patients on Hemodialysis

Clinical journal of the American Society of Nephrology, 2013-12, Vol.8 (12), p.2132-2140

2013

Volltextzugriff (PDF)

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

Kidney international, 2005-10, Vol.68 (4), p.1815-1824

2005

Volltextzugriff (PDF)

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis

Journal of the American Society of Nephrology, 2004-08, Vol.15 (8), p.2208-2218

2004

Volltextzugriff (PDF)

A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial

Journal of the American Society of Nephrology, 2020-01, Vol.31 (1), p.161-174

2020

Volltextzugriff (PDF)

Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study

The American journal of clinical nutrition, 2014-11, Vol.100 (5), p.1392-1397

2014

Volltextzugriff (PDF)

An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism

PloS one, 2019-03, Vol.14 (3), p.e0213774-e0213774

2019

Volltextzugriff (PDF)

Phosphate Homeostasis in CKD: Report of a Scientific Symposium Sponsored by the National Kidney Foundation

American journal of kidney diseases, 2013-09, Vol.62 (3), p.457-473

2013

Volltextzugriff (PDF)

Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease

PloS one, 2017-11, Vol.12 (11), p.e0188712-e0188712

2017

Volltextzugriff (PDF)

Dosing of Etelcalcetide vs Cinacalcet for Secondary Hyperparathyroidism-Reply

JAMA : the journal of the American Medical Association, 2017-05, Vol.317 (20), p.2132

2017

Volltextzugriff (PDF)

All-cause Mortality in Hemodialysis Patients with Heart Valve Calcification

Clinical journal of the American Society of Nephrology, 2011-08, Vol.6 (8), p.1990-1995

2011

Volltextzugriff (PDF)

Ferric Citrate in Patients With Chronic Kidney Disease

Seminars in nephrology, 2016-03, Vol.36 (2), p.130-135

Block, Geoffrey A., MD

2016

Volltextzugriff (PDF)

1 – 25 von 462

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(420)
Mit Volltextzugriff
(403)

Publikationsform

Sprache

Englisch
(462)

Erscheinungsjahr

n.n

Thema

Science & Technology
(204)
Life Sciences & Biomedicine
(200)
Humans
(183)
Male
(138)
Female
(132)
Middle Aged
(118)
Urology & Nephrology
(116)
Aged
(77)
Adult
(71)
Biological And Medical Sciences
(54)
Medical Sciences
(52)
Renal Dialysis
(42)
Kidney Failure, Chronic - Therapy
(39)
Treatment Outcome
(36)
Hemodialysis
(35)
Double-Blind Method
(30)
Risk Factors
(30)
Chronic Kidney Disease
(28)
Composers
(28)
Kidney Failure, Chronic - Complications
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis

A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD

SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey

Effects of Phosphate Binders in Moderate CKD

Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial

Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis

Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5

Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD

Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosis

CKD–Mineral and Bone Disorder and Risk of Death and Cardiovascular Hospitalization in Patients on Hemodialysis

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis

A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial

Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study

An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism

Phosphate Homeostasis in CKD: Report of a Scientific Symposium Sponsored by the National Kidney Foundation

Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease

Dosing of Etelcalcetide vs Cinacalcet for Secondary Hyperparathyroidism-Reply

All-cause Mortality in Hemodialysis Patients with Heart Valve Calcification

Ferric Citrate in Patients With Chronic Kidney Disease

Suchergebnisse filtern